Form 8-K Summary
Registrant: Sarcos Technology and Robotics Corporation (the filing predates the company name shown in the request metadata as Palladyne AI Corp.)
Report date: October 24, 2023; filed October 27, 2023. The filing concerns a Nasdaq continued-listing deficiency and does not report quarterly or annual operating results.
Business Context and Reporting Period
The company reported receiving written notice from Nasdaq that its common stock had traded below the required minimum closing bid price of $1.00 for 30 consecutive business days. The common stock traded under the symbol STRC, and redeemable warrants traded under STRCW.
Financial and Listing Metrics
- Minimum bid-price requirement: $1.00 per share.
- Deficiency period: 30 consecutive business days below the required bid price.
- Initial compliance deadline: April 22, 2024.
- Required cure: A closing bid price of at least $1.00 for a minimum of 10 consecutive business days, subject to Nasdaq’s other listing requirements.
- Revenue, profit, cash flow, margins, debt, and liquidity: The filing text does not provide clear values for these metrics.
Material Changes and Management Response
The notice does not immediately affect the listing of the common stock on Nasdaq Global Market. The company stated that it would monitor its closing bid price and evaluate available alternatives, which could include effecting a reverse stock split.
If the company does not regain compliance by April 22, 2024, it may be eligible to transfer to the Nasdaq Capital Market and receive an additional 180-day compliance period, provided it satisfies applicable listing standards and gives Nasdaq written notice of its intention to cure the deficiency. Nasdaq may determine that an extension is unavailable if it does not appear possible for the company to cure the deficiency.
Outlook, Risks, and Contingencies
- Failure to regain compliance within the applicable period or periods could result in a Nasdaq delisting notice.
- The company may appeal a delisting determination, but there is no assurance that an appeal would succeed.
- A reverse stock split is only a potential action; the filing provides no terms, timing, shareholder approvals, or assurance that it would be implemented.
- The company may need to satisfy additional Nasdaq listing criteria, including market-value requirements for publicly held shares.
- Management’s statements regarding regaining compliance, obtaining additional time, or receiving Nasdaq relief are forward-looking and subject to substantial uncertainty.
Investor Verification Items
- Confirm whether the company subsequently regained compliance by April 22, 2024 or received an additional compliance period.
- Verify any subsequent reverse stock split, share-price changes, or Nasdaq listing-status notices.
- Review later SEC filings for the company’s financial condition, liquidity, capital needs, and any delisting-related consequences.
- Confirm the company’s current legal name, ticker symbols, and exchange listing status, given the difference between the request metadata and the filing’s stated registrant name.